Why are biogenerics so hard to regulate?
There’s been a lot of press floating around lately about the push to develop a framework for biogeneric (or biosimilar, […]
General Biotechnology
2007
General Biotechnology
Open Biotechnology Journal
I’ve been invited to join the editorial board of the nascent Open Biotechnology Journal. The Open Biotechnology Journal is a
General Biotechnology
Carnival of Biotechnology
Scientific Advances The MaRS Blog has a captivating story of Canada’s recent major diabetes discovery. The first discovery, in 1920,
General Biotechnology
Carnival of Biotechnology
This edition of the Carnival of Biotechnology features a number of posts on distressing industry trends, some enlightening patent discussion,
General Biotechnology, Guest content
Lessons and analogies from other industries
Guest content from John Avellanet, managing director of Cerulean Associates: As professionals affiliated with the biotechnology industry, we often forget
General Biotechnology
Can Science Be a Business?
Harvard’s Gary Pisano has recently published a book titled “Science Business: The Promise, the Reality, and the Future of Biotech“